UBS Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.2M | Buy |
307,728
+200,731
| +188% | +$17.9M | ﹤0.01% | 2302 |
|
|
2025
Q4 | $8.45M | Buy |
106,997
+100,000
| +1,429% | +$7.84M | ﹤0.01% | 3467 |
|
|
2025
Q3 | $559K | Buy |
6,997
+6,497
| +1,299% | +$554K | ﹤0.01% | 6010 |
|
|
2025
Q2 | $45.5K | Sell |
500
-41,012
| -99% | -$3.74M | ﹤0.01% | 7852 |
|
|
2025
Q1 | $3.89M | Sell |
41,512
-57,188
| -58% | -$5.12M | ﹤0.01% | 4039 |
|
|
2024
Q4 | $8.97M | Hold |
98,700
| – | – | ﹤0.01% | 3180 |
|
|
2024
Q3 | $10.2M | Buy |
98,700
+30,000
| +44% | +$3.06M | ﹤0.01% | 2346 |
|
|
2024
Q2 | $6.67M | Sell |
68,700
-81,100
| -54% | -$7.48M | ﹤0.01% | 2580 |
|
|
2024
Q1 | $13.5M | Sell |
149,800
-1,034,900
| -87% | -$87.7M | ﹤0.01% | 2019 |
|
|
2023
Q4 | $94.4M | Buy |
1,184,700
+41,800
| +4% | +$3.14M | 0.03% | 596 |
|
|
2023
Q3 | $81.3M | Sell |
1,142,900
-105,100
| -8% | -$7.86M | 0.03% | 587 |
|
|
2023
Q2 | $96.1M | Sell |
1,248,000
-831,700
| -40% | -$64.4M | 0.03% | 514 |
|
|
2023
Q1 | $156M | Buy |
2,079,700
+2,012,700
| +3,004% | +$150M | 0.06% | 329 |
|
|
2022
Q4 | $5.28M | Hold |
67,000
| – | – | ﹤0.01% | 2454 |
|
|
2022
Q3 | $4.71M | Buy |
67,000
+37,000
| +123% | +$2.9M | ﹤0.01% | 2405 |
|
|
2022
Q2 | $2.4M | Buy |
+30,000
| New | +$2.35M | ﹤0.01% | 2990 |
|
|
2022
Q1 | – | Sell |
-30,000
| Closed | -$2.56M | – | 10310 |
|
|
2021
Q4 | $2.56M | Sell |
30,000
-21,341
| -42% | -$1.67M | ﹤0.01% | 3515 |
|
|
2021
Q3 | $3.88M | Buy |
51,341
+30,000
| +141% | +$2.38M | ﹤0.01% | 2945 |
|
|
2021
Q2 | $1.74M | Sell |
21,341
-106,860
| -83% | -$8.74M | ﹤0.01% | 3710 |
|
|
2021
Q1 | $10.1M | Buy |
128,201
+42,686
| +50% | +$3.35M | ﹤0.01% | 1940 |
|
|
2020
Q4 | $7.31M | Buy |
85,515
+34,875
| +69% | +$2.88M | ﹤0.01% | 2112 |
|
|
2020
Q3 | $3.91M | Buy |
+50,640
| New | +$3.86M | ﹤0.01% | 2427 |
|
|
2020
Q1 | – | Sell |
-90,000
| Closed | -$6.2M | – | 8000 |
|
|
2019
Q4 | $6.2M | Hold |
90,000
| – | – | ﹤0.01% | 2406 |
|
|
2019
Q3 | $6.62M | Buy |
90,000
+50,000
| +125% | +$3.63M | ﹤0.01% | 2124 |
|
|
2019
Q2 | $2.87M | Buy |
+40,000
| New | +$2.84M | ﹤0.01% | 2825 |
|
|
2018
Q4 | – | Sell |
-201,000
| Closed | -$13.5M | – | 8048 |
|
|
2018
Q3 | $13.5M | Buy |
201,000
+5,000
| +3% | +$333K | 0.01% | 1526 |
|
|
2018
Q2 | $12.7M | Buy |
+196,000
| New | +$12.8M | 0.01% | 1534 |
|
|
2018
Q1 | – | Sell |
-13,500
| Closed | -$1.02M | – | 7839 |
|
|
2017
Q4 | $1.02M | Buy |
+13,500
| New | +$986K | ﹤0.01% | 3771 |
|
|
2017
Q3 | – | Sell |
-70,100
| Closed | -$5.2M | – | 7739 |
|
|
2017
Q2 | $5.2M | Sell |
70,100
-264,850
| -79% | -$19.7M | ﹤0.01% | 2116 |
|
|
2017
Q1 | $24.5M | Buy |
334,950
+54,950
| +20% | +$3.85M | 0.01% | 908 |
|
|
2016
Q4 | $18.3M | Buy |
280,000
+203,200
| +265% | +$13.9M | 0.01% | 1078 |
|
|
2016
Q3 | $5.69M | Sell |
76,800
-44,700
| -37% | -$3.3M | ﹤0.01% | 1908 |
|
|
2016
Q2 | $8.89M | Buy |
121,500
+41,270
| +51% | +$2.94M | 0.01% | 1472 |
|
|
2016
Q1 | $5.67M | Buy |
80,230
+49,230
| +159% | +$3.28M | ﹤0.01% | 1756 |
|
|
2015
Q4 | $2.06M | Buy |
+31,000
| New | +$2.06M | ﹤0.01% | 2760 |
|
|
2015
Q3 | – | Sell |
-14,500
| Closed | -$948K | – | 8429 |
|
|
2015
Q2 | $948K | Sell |
14,500
-63,000
| -81% | -$4.27M | ﹤0.01% | 3612 |
|
|
2015
Q1 | $5.37M | Buy |
77,500
+46,300
| +148% | +$3.2M | ﹤0.01% | 2013 |
|
|
2014
Q4 | $2.16M | Buy |
+31,200
| New | +$2.11M | ﹤0.01% | 2841 |
|
Other funds holding CL
VCM
DAM
VPM
UBS Group's CL Position: Q1 2026 in Review
UBS Group increased its Colgate-Palmolive (CL) stake by 1.4% in Q1 2026, buying an estimated $5.7M and bringing the position to 4,614,605 shares worth $393M. The position accounts for 0.06% of the portfolio, ranked #336.
UBS Group first reported a position in CL in Q4 2014 and has held it in 46 quarters since. The position peaked at $977M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- UBS Group held 4,614,605 shares of Colgate-Palmolive worth $393M as of Q1 2026.
- UBS Group bought 63,913 Colgate-Palmolive shares in Q1 2026, an estimated $5.7M.
- Colgate-Palmolive made up 0.06% of UBS Group's portfolio in Q1 2026, its #336 holding.
- UBS Group first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Colgate-Palmolive position peaked at $977M in Q1 2018.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.